The Zacks Analyst Blog Highlights: Agilent Technologies, STMicroelectronics …
However, more than the Lexapro impact, we were disappointed to see Forest Labs cut its revenue expectations for Namenda. The company now expects Namenda sales to grow 11% in fiscal 2013 instead of 17%. This means that Namenda s sales will be …
Full News here – Read more on Zacks.com
link: The Zacks Analyst Blog Highlights: Agilent Technologies, STMicroelectronics …
